A Study Comparing the Dulaglutide Pen and the Semaglutide Pen
Public ClinicalTrials.gov record NCT03724981. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Crossover Study Comparing the Dulaglutide (Trulicity) Pen and the Semaglutide (Ozempic) Pen
Study identification
- NCT ID
- NCT03724981
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 312 participants
Conditions and interventions
Conditions
Interventions
- Dulaglutide Pen Drug
- Semaglutide Pen Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 17, 2018
- Primary completion
- Apr 11, 2019
- Completion
- Apr 11, 2019
- Last update posted
- Apr 23, 2020
2018 – 2019
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Valley Research | Fresno | California | 93720 | — |
| Long Beach Center for Clinical Research | Long Beach | California | 90807 | — |
| Palm Harbor Medical Associates | Palm Harbor | Florida | 34684 | — |
| Georgia Clinical Research | Snellville | Georgia | 30078 | — |
| Cedar-Crosse Research Center | Chicago | Illinois | 60607 | — |
| L-Marc Research Center | Louisville | Kentucky | 40213 | — |
| Evidera | Bethesda | Maryland | 20814 | — |
| Carolina Research Center, Inc. | Shelby | North Carolina | 28150 | — |
| Lillestol Research LLC | Fargo | North Dakota | 58104 | — |
| BRCR Medical Center, Inc. | Camp Hill | Pennsylvania | 17011 | — |
| Juno Research | Houston | Texas | 77040 | — |
| Juno Research, LLC | Houston | Texas | 77054 | — |
| PI-Coor Clinical Research, LLC | Annandale | Virginia | 22003 | — |
| Manassas Clinical Research Center | Manassas | Virginia | 20110 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03724981, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 23, 2020 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03724981 live on ClinicalTrials.gov.